Bär & Karrer has advised the banks in Molecular Partners’ initial public offering (IPO), which closed on 7 November 2014. The Swiss biopharmaceutical company’s shares were first listed and traded on the SIX Swiss Exchange on 5 November 2014.
JP Morgan Securities acted as global co-ordinator and together with UBS as joint bookrunner. Cowen and Company and Bank am Bellevue acted as co-managers.
Bär & Karrer advised the banks in this IPO. The team included Till Spillmann, Thomas U Reutter (both capital markets), Markus Wang (intellectual property), Raoul Stocker (tax), Annette Weber, Fabian Wigger, Ivo von Büren and Annina Hammer.